Eunice EunKyeong Kim

1.9k total citations
84 papers, 1.5k citations indexed

About

Eunice EunKyeong Kim is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eunice EunKyeong Kim has authored 84 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 25 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in Eunice EunKyeong Kim's work include Ubiquitin and proteasome pathways (23 papers), Peptidase Inhibition and Analysis (14 papers) and Cancer-related Molecular Pathways (9 papers). Eunice EunKyeong Kim is often cited by papers focused on Ubiquitin and proteasome pathways (23 papers), Peptidase Inhibition and Analysis (14 papers) and Cancer-related Molecular Pathways (9 papers). Eunice EunKyeong Kim collaborates with scholars based in South Korea, United States and Egypt. Eunice EunKyeong Kim's co-authors include Eun Joo Song, Sang Chul Shin, Kwang Yeon Hwang, Joon Kyu Park, Amit Priyadarshi, Byung Hak Ha, Jin‐Young Park, Mihue Jang, Young Sook Yoo and Jinhong Cho and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Eunice EunKyeong Kim

84 papers receiving 1.5k citations

Peers

Eunice EunKyeong Kim

ONCOL

GENET

Jianye Zang China

Darcie J. Miller United States

H. Gut Switzerland

Yingqiu Xie Kazakhstan

Adrian Drazic Norway

Paola Lo Surdo Italy

Jeffrey Tom United States

M. Brett Waddell United States

Falko Hochgräfe Germany

Wael M. Rabeh United Arab Emirates

Jianye Zang China

Eunice EunKyeong Kim

1.8k ×1.7

186 ×0.7

ONCOL

248 ×1.2

178 ×1.1

195 ×1.2

GENET

Citations per year, relative to Eunice EunKyeong Kim Eunice EunKyeong Kim (= 1×) peers Jianye Zang

Countries citing papers authored by Eunice EunKyeong Kim

Since Specialization

Citations

This map shows the geographic impact of Eunice EunKyeong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunice EunKyeong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunice EunKyeong Kim more than expected).

Fields of papers citing papers by Eunice EunKyeong Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eunice EunKyeong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunice EunKyeong Kim. The network helps show where Eunice EunKyeong Kim may publish in the future.

Co-authorship network of co-authors of Eunice EunKyeong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Eunice EunKyeong Kim. A scholar is included among the top collaborators of Eunice EunKyeong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eunice EunKyeong Kim. Eunice EunKyeong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shin, Sang Chul, Yeonji Oh, Jin Hyeok Kim, et al.. (2025). Targeting USP47 enhances the efficacy of KRAS inhibitor in KRASG12C mutated non-small cell lung cancer by controlling deubiquitination of c-Myc. Pharmacological Research. 215. 107722–107722. 1 indexed citations

Gunasekaran, P., Jihyeon Lee, Tae Wan Kim, et al.. (2025). N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics. 17(8). 1027–1027. 1 indexed citations

Abdel‐Maksoud, Mohammed S., Eslam M.H. Ali, Usama M. Ammar, et al.. (2023). Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells. European Journal of Medicinal Chemistry. 261. 115779–115779. 8 indexed citations

Song, Chiman, et al.. (2023). Structural basis for CEP192-mediated regulation of centrosomal AURKA. Science Advances. 9(16). eadf8582–eadf8582. 11 indexed citations

Jang, Hochung, Hyo‐Suk Kim, Eun Hye Kim, et al.. (2023). Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery. Biomaterials Research. 27(1). 124–124. 24 indexed citations

Ali, Eslam M.H., Usama M. Ammar, Seyed–Omar Zaraei, et al.. (2022). Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study. European Journal of Pharmaceutical Sciences. 171. 106115–106115. 13 indexed citations

El‐Damasy, Ashraf K., Seon Hee Seo, Young Ho Seo, et al.. (2020). Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90. International Journal of Molecular Sciences. 21(24). 9377–9377. 9 indexed citations

Ju, Anna, Sung Won Lee, Young Eun Lee, et al.. (2019). A carrier-free multiplexed gene editing system applicable for suspension cells. Biomaterials. 217. 119298–119298. 28 indexed citations

Park, Joon Kyu, et al.. (2017). USP15 regulates dynamic protein–protein interactions of the spliceosome through deubiquitination of PRP31. Nucleic Acids Research. 45(8). gkw1365–gkw1365. 36 indexed citations

10.

Lee, Hyung Ki, et al.. (2017). Unique binding mode of Evogliptin with human dipeptidyl peptidase IV. Biochemical and Biophysical Research Communications. 494(3-4). 452–459. 13 indexed citations

11.

Kim, Kyung‐Hee, Weontae Lee, & Eunice EunKyeong Kim. (2016). Crystal structures of human peroxiredoxin 6 in different oxidation states. Biochemical and Biophysical Research Communications. 477(4). 717–722. 36 indexed citations

12.

Shin, Sang Chul, Seon Hee Seo, Young Ho Seo, et al.. (2016). Synthesis and in vitro antiproliferative activity of C5-benzyl substituted 2-amino-pyrrolo[2,3-d]pyrimidines as potent Hsp90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(2). 237–241. 15 indexed citations

13.

Ha, Byung Hak, et al.. (2016). Structural and biochemical characterization of FabK from Thermotoga maritima. Biochemical and Biophysical Research Communications. 482(4). 968–974. 2 indexed citations

14.

Kim, Su Jin, Eun Joo Song, Soo Jin Kim, et al.. (2014). Structural Basis for Ovarian Tumor Domain-containing Protein 1 (OTU1) Binding to p97/Valosin-containing Protein (VCP). Journal of Biological Chemistry. 289(18). 12264–12274. 24 indexed citations

15.

Priyadarshi, Amit, et al.. (2010). Structural insights into mouse anti-apoptotic Bcl-xl reveal affinity for Beclin 1 and gossypol. Biochemical and Biophysical Research Communications. 394(3). 515–521. 13 indexed citations

16.

Ha, Byung Hak, et al.. (2010). Crystal Structures of Enoyl-ACP Reductases I (FabI) and III (FabL) from B. subtilis. Journal of Molecular Biology. 406(3). 403–415. 36 indexed citations

17.

Priyadarshi, Amit, Eunice EunKyeong Kim, & Kwang Yeon Hwang. (2009). Structural and functional analysis of Vitamin K2 synthesis protein MenD. Biochemical and Biophysical Research Communications. 388(4). 748–751. 7 indexed citations

18.

Park, Joon Kyu, Jae‐Jin Lee, Yun‐Seok Choi, et al.. (2009). Structure and interaction of ubiquitin‐associated domain of human Fas‐associated factor 1. Protein Science. 18(11). 2265–2276. 23 indexed citations

19.

Kim, Eunice EunKyeong, et al.. (2008). Structures of proteases for ubiqutin and ubiquitin-like modifiers. BMB Reports. 41(6). 435–443. 20 indexed citations

20.

Park, Joon Kyu, et al.. (2007). Structural Basis for Glutamate Racemase Inhibition. Journal of Molecular Biology. 372(2). 434–443. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact